Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Mabvax Therapeutics Holdings Inc

TRADE

NASDAQ: MBVXHealthcare / Biotechnology / USA
0.89-0.03-3.26%Vol 35 0401Y Perf -67.03%
Jul 20th, 2018 15:59
BID0.00 ASK0.00
Open0.92 Previous Close0.92
Pre-Market- After-Trading-
 - -%  - -%
Target Price
15.00 
Analyst Rating
— 0.00
Potencial %
1 585.39 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-100/-100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-100/-100 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/-100/-100 
Income Ranking
 —    -
Market Cap (mil)8 
Earnings Rating
Neutral
Price Range Ratio 52wk %
14.10 
Earnings Date
13th Aug 2018

Today's Price Range

0.890.92

 

52wk Range

0.453.57

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Buy
Performance
1 Month
-6.32%
3 Months
-41.83%
6 Months
1.14%
1 Year
-67.03%
3 Years
-94.16%
5 Years
-98.90%

Quotes

Name / TickerPriceChg.Chg.%
MBVX0.89-0.0300-3.26
AAPL191.44-0.4400-0.23
GOOG1 184.91-2.0500-0.17
MSFT106.271.87001.79
XOM81.40-0.6100-0.74
WFC56.410.08000.14
JNJ125.85-0.0900-0.07
FB209.941.85000.89
GE13.12-0.6100-4.44
JPM111.281.39001.26
...

TickerPriceChg.%52 Week High
CTAS203.575.11204.27
PM84.314.22120.00
VFC92.944.1593.51
HON153.133.79165.13
SWK144.233.28176.62
PDCO23.642.8743.20
DOV80.242.7188.11
STI70.842.6473.37
ADS233.082.59278.33
NUE66.252.4470.48
KSU111.052.40114.91
IDXX248.142.19248.65
COF97.231.95106.50
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 0.20
Current Ratio 0.20
Long Term Debt to Total Capital 0.60
Total Debt to Equity 3.01
Interest Coverage -84.60
Leverage Ratio 7.80
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-
EBIT Margin-2 763.70
EBITDA Margin-2 745.00
Pre-tax Profit Margin-5 782.00
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 7.56
PS Ratios -
Price to Cash Flow -
Price to Free Cash Flow -1.70
Cash Flow Per Share -2.87
Price to Tangible Book-1.48
Book Value per Share0.13
Enterprise Value (in ths.)10 959
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-4 727.30
ROE last 12 Months -1 331.91
Return on Assets (5Y Avg) -191.75
ROA last 12 Months -291.45
Return on Capital (5Y Avg) -642.29
ROC last 12 Months -303.10
Return on invested Capital Q -187.08
Return on invested Capital Y-534.45
Assets Turnover0.00
Receivables Turnover0.00
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)0
Revenue per Share 0.00
Revenue Growth 3 Years -
Revenue Growth 5 Years -
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q03 2017--1.62-
Q02 2017--4.41-
Q01 2017--2.55-
Q03 2016-2.22-2.58-16.22
Q02 2016-1.41-0.8936.88
Q01 2016-1.18-1.115.93
Q02 2015-0.89-2.15-141.57
Q01 2015--6.25-
Earnings Per EndEstimateRevision %Trend
12/2016 QR-0.690.00-
12/2017 FY-3.010.00-
12/2018 FY-2.930.00-
----
Next Report Date13th Aug 2018
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume35 040
Shares Outstanding (in ths.)8 960
Trades Count10
Dollar Volume28 399
Avg. Volume302 169
Avg. Weekly Volume125 208
Avg. Monthly Volume1 402 127
Avg. Quarterly Volume511 629

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

67%33%

Bearish Bullish

77%23%

Bearish Bullish

64%36%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
1 (100.00 %)
Moderate Buy
0
0
0 (0.00 %)
Hold
0
0
0 (0.00 %)
Moderate Sell
0
0
0 (0.00 %)
Strong Sell
0
0
0 (0.00 %)
Rating--Strong Buy
1.00

There are no comments yet.

News

x